GLPwatch
Ozempic vs Saxenda
Drug comparison
Last updated 2026-05-28 15:46 UTCOzempic (semaglutide) and Saxenda (liraglutide) are both injectable medications made by Novo Nordisk. Ozempic is FDA-approved to treat type 2 diabetes, reduce cardiovascular risk, and manage chronic kidney disease, while Saxenda is approved for weight management in obesity.
AI summary of the sources below.
| Ozempic | Saxenda | |
|---|---|---|
| Active ingredient | semaglutide | liraglutide |
| Manufacturer | novo-nordisk | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes, cardiovascular risk reduction, chronic kidney disease | obesity |
| Label updated | 2026-01-30 | 2026-02-25 |